RSLS logo

ReShape Lifesciences (RSLS) Gross Margin

Annual Gross Margin

63.93%
+3.41%+5.63%

December 31, 2023


Summary


Performance

RSLS Gross Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRSLSprofitabilitymetrics:

Quarterly Gross Margin

62.78%
+5.07%+8.79%

September 30, 2024


Summary


Performance

RSLS Quarterly Gross Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRSLSprofitabilitymetrics:

Gross Margin Formula

Gross Margin =  Gross Profit
Revenue
✕ 100%

RSLS Gross Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+5.6%+5.0%
3 y3 years+15.4%+9.0%
5 y5 years-12.4%-0.9%

RSLS Gross Margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+5.6%-32.5%+25.8%
5 y5-yearat high+15.4%-32.5%+27.6%
alltimeall time-12.4%+149.1%-32.5%+133.5%

ReShape Lifesciences Gross Margin History

DateAnnualQuarterly
Sep 2024
-
62.78%(+8.8%)
Jun 2024
-
57.71%(-3.7%)
Mar 2024
-
59.93%(-35.5%)
Dec 2023
63.93%(+5.6%)
92.94%(+55.5%)
Sep 2023
-
59.77%(+12.8%)
Jun 2023
-
52.97%(-1.0%)
Mar 2023
-
53.52%(+4.0%)
Dec 2022
60.52%(-1.4%)
51.45%(-31.5%)
Sep 2022
-
75.09%(+15.3%)
Jun 2022
-
65.11%(+30.4%)
Mar 2022
-
49.92%(-11.7%)
Dec 2021
61.38%(+10.8%)
56.52%(-1.8%)
Sep 2021
-
57.58%(-5.6%)
Jun 2021
-
61.01%(-14.0%)
Mar 2021
-
70.91%(+38.6%)
Dec 2020
55.42%(-10.1%)
51.17%(-19.2%)
Sep 2020
-
63.33%(+28.8%)
Jun 2020
-
49.18%(-8.8%)
Mar 2020
-
53.93%(+3.3%)
Dec 2019
61.67%
52.22%(-12.7%)
DateAnnualQuarterly
Sep 2019
-
59.80%(-6.9%)
Jun 2019
-
64.20%(-11.5%)
Mar 2019
-
72.58%(-12.2%)
Dec 2018
72.98%(+76.1%)
82.67%(-144.1%)
Sep 2018
-
-187.50%(-367.9%)
Jun 2018
-
70.00%(+23.2%)
Mar 2018
-
56.83%(+4.7%)
Dec 2017
41.44%(-8.2%)
54.27%(+34.3%)
Sep 2017
-
40.42%(-2.5%)
Jun 2017
-
41.47%(+57.9%)
Mar 2017
-
26.27%(-29.0%)
Dec 2016
45.15%(-21.0%)
36.99%(-26.9%)
Sep 2016
-
50.59%(+15.7%)
Jun 2016
-
43.73%(-1.2%)
Mar 2016
-
44.26%(-15.5%)
Dec 2015
57.18%(+122.8%)
52.39%(-17.5%)
Sep 2015
-
63.52%(+4.0%)
Jun 2015
-
61.06%(+171.4%)
Dec 2012
25.67%
-
Jun 2012
-
22.50%(-26.3%)
Mar 2012
-
30.53%

FAQ

  • What is ReShape Lifesciences annual gross profit margin?
  • What is the all time high annual gross margin for ReShape Lifesciences?
  • What is ReShape Lifesciences annual gross margin year-on-year change?
  • What is ReShape Lifesciences quarterly gross profit margin?
  • What is the all time high quarterly gross margin for ReShape Lifesciences?
  • What is ReShape Lifesciences quarterly gross margin year-on-year change?

What is ReShape Lifesciences annual gross profit margin?

The current annual gross margin of RSLS is 63.93%

What is the all time high annual gross margin for ReShape Lifesciences?

ReShape Lifesciences all-time high annual gross profit margin is 72.98%

What is ReShape Lifesciences annual gross margin year-on-year change?

Over the past year, RSLS annual gross profit margin has changed by +3.41% (+5.63%)

What is ReShape Lifesciences quarterly gross profit margin?

The current quarterly gross margin of RSLS is 62.78%

What is the all time high quarterly gross margin for ReShape Lifesciences?

ReShape Lifesciences all-time high quarterly gross profit margin is 92.94%

What is ReShape Lifesciences quarterly gross margin year-on-year change?

Over the past year, RSLS quarterly gross profit margin has changed by +3.01% (+5.04%)